New therapies show promise for patients with leukemia, hemophilia, and heart disease.
Stephenson
J
J
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015316:Genetic Therapy; D006331:Heart Diseases / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D007938:Leukemia / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate